Cargando…

Heterogeneity of KRAS Mutation Status in Rectal Cancer

INTRODUCTION: Anti-EGFR targeted therapy is of increasing importance in advanced colorectal cancer and prior KRAS mutation testing is mandatory for therapy. However, at which occasions this should be performed is still under debate. We aimed to assess in patients with locally advanced rectal cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Peter, König, Alexander, Schirmer, Markus, Kitz, Julia, Conradi, Lena-Christin, Azizian, Azadeh, Bernhardt, Markus, Wolff, Hendrik A., Grade, Marian, Ghadimi, Michael, Ströbel, Philipp, Schildhaus, Hans-Ulrich, Gaedcke, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827807/ https://www.ncbi.nlm.nih.gov/pubmed/27064574 http://dx.doi.org/10.1371/journal.pone.0153278

Ejemplares similares

KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer
por: Jo, Peter, et al.
Publicado: (2020)

Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
por: Azizian, Azadeh, et al.
Publicado: (2016)

Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy
por: Jo, Peter, et al.
Publicado: (2017)

The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies
por: Grade, Marian, et al.
Publicado: (2012)

Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection
por: Bernhardt, Markus, et al.
Publicado: (2023)

Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
por: Jo, Peter, et al.
Publicado: (2016)

Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer
por: Flebbe, Hannah, et al.
Publicado: (2019)

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy
por: Emons, Georg, et al.
Publicado: (2022)

CA19-9 for detecting recurrence of pancreatic cancer
por: Azizian, Azadeh, et al.
Publicado: (2020)

Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer
por: Gaedcke, Jochen, et al.
Publicado: (2014)

Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
por: Dröge, Leif Hendrik, et al.
Publicado: (2015)

Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019)

Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
por: Conradi, Lena-Christin, et al.
Publicado: (2011)

Incidence, Associated Risk Factors, and Outcomes of Postoperative Arrhythmia After Upper Gastrointestinal Surgery
por: Rühlmann, Felix, et al.
Publicado: (2022)

Incidence and impact of new-onset postoperative arrhythmia after surgery of the lower gastrointestinal tract
por: Rühlmann, Felix, et al.
Publicado: (2023)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

8-Oxoguanine DNA Glycosylase (OGG1) Cys326 Variant: Increased Risk for Worse Outcome of Patients with Locally Advanced Rectal Cancer after Multimodal Therapy
por: Leu, Martin, et al.
Publicado: (2021)

Surgical treatment of metastatic VIPoma: a case report
por: Azizian, Azadeh, et al.
Publicado: (2021)

Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
por: Koerdel, Kristin, et al.
Publicado: (2021)

The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
por: Rühlmann, Felix, et al.
Publicado: (2017)

Comparing Apparent Diffusion Coefficient and FNCLCC Grading to Improve Pretreatment Grading of Soft Tissue Sarcoma—A Translational Feasibility Study on Fusion Imaging
por: Hettler, Madelaine, et al.
Publicado: (2022)

Volumetric Modulated Arc Therapy Improves Outcomes in Definitive Radiochemotherapy for Anal Cancer Whilst Reducing Acute Toxicities and Increasing Treatment Compliance
por: Possiel, Jacqueline, et al.
Publicado: (2021)

Treatment options of metastatic and nonmetastatic VIPoma: a review
por: Azizian, Azadeh, et al.
Publicado: (2022)

Vascular Heterogeneity With a Special Focus on the Hepatic Microenvironment
por: Fleischer, Johannes Robert, et al.
Publicado: (2020)

Implications of Rectal Cancer Radiotherapy on the Immune Microenvironment: Allies and Foes to Therapy Resistance and Patients’ Outcome
por: Sartorius, Dorothée, et al.
Publicado: (2023)

Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas
por: Peng, Luogen, et al.
Publicado: (2023)

Distinct Chromosomal Profiles in Metastasizing and Non-Metastasizing Colorectal Carcinomas
por: Ghadimi, B. Michael, et al.
Publicado: (2006)

Pelvic intraoperative neuromonitoring during robotic-assisted low anterior resection for rectal cancer
por: Grade, Marian, et al.
Publicado: (2015)

Impact of RNA degradation on gene expression profiling
por: Opitz, Lennart, et al.
Publicado: (2010)

STED Super-Resolution Microscopy of Clinical Paraffin-Embedded Human Rectal Cancer Tissue
por: Ilgen, Peter, et al.
Publicado: (2014)

Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy
por: Flebbe, Hannah, et al.
Publicado: (2022)

STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
por: Spitzner, Melanie, et al.
Publicado: (2014)

HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer
por: Styczen, Hanna, et al.
Publicado: (2015)

Personalmanagement und Leadership in der Chirurgie
por: Grade, Marian, et al.
Publicado: (2021)

The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials
por: Gaedcke, J., et al.
Publicado: (2009)

A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells
por: Wolff, Alexander, et al.
Publicado: (2018)

Correction: A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells
por: Wolff, Alexander, et al.
Publicado: (2019)

Effectiveness of fourth-line dual immunotherapy in hepatocellular carcinoma with simultaneous steroid administration for immune-related hepatitis
por: Lowes, Kristina, et al.
Publicado: (2022)

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome
por: Menck, Kerstin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oso1i48i76vcnh98pqet3fhsfg